Tkaczyk, C., Semenova, E., Shi, Y. Y., Rosenthal, K., Oganesyan, V., Warrener, P., . . . Sellman, B. R. (2018). Alanine Scanning Mutagenesis of the MEDI4893 (Suvratoxumab) Epitope Reduces Alpha Toxin Lytic Activity In Vitro and Staphylococcus aureus Fitness in Infection Models. Antimicrob Agents Chemother.

Tkaczyk, C., E. Semenova, Y. Y. Shi, K. Rosenthal, V. Oganesyan, P. Warrener, C. K. Stover, and B. R. Sellman. "Alanine Scanning Mutagenesis of the MEDI4893 (Suvratoxumab) Epitope Reduces Alpha Toxin Lytic Activity In Vitro and Staphylococcus Aureus Fitness in Infection Models." Antimicrob Agents Chemother 2018.

Tkaczyk, C., et al. "Alanine Scanning Mutagenesis of the MEDI4893 (Suvratoxumab) Epitope Reduces Alpha Toxin Lytic Activity In Vitro and Staphylococcus Aureus Fitness in Infection Models." Antimicrob Agents Chemother 2018.